3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
14
Non-Muscle Invasive Bladder Neoplasms
10
Colorectal Neoplasms
7
Appendiceal Neoplasms
6
Anus Neoplasms
6
Peritoneal Neoplasms
5
Carcinoma, Transitional Cell
5
Stomach Neoplasms
2
Pseudomyxoma Peritonei
2
Ovarian Neoplasms
2
Uterine Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Urinary Bladder Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Recurrence
1
Rectal Neoplasms
1
Pleural Neoplasms
1
Peritoneal Diseases
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Metastasis
1
Necrosis
1
Nasopharyngeal Carcinoma
1
Mediastinal Neoplasms
1
Male Urogenital Diseases
1
Interventions
Gemcitabine
113
130-nm albumin-bound paclitaxel
64
Albumin-Bound Paclitaxel
43
Fluorouracil
37
Magnetic Resonance Spectroscopy
35
pembrolizumab
34
Irinotecan
34
Taxes
33
Specimen Handling
33
Leucovorin
33
Oxaliplatin
31
Biopsy
22
Cyclophosphamide
21
Nivolumab
18
fludarabine
16
Radiosurgery
16
Cisplatin
16
Drug Therapy
15
Capecitabine
12
folfirinox
11
durvalumab
11
Radiotherapy
11
irinotecan sucrosofate
10
Ipilimumab
10
Cetuximab
10
Carboplatin
10
Blood Specimen Collection
10
olaparib
9
Standard of Care
9
dehydroftorafur
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pancreatic Neoplasms
×
Mitomycin
×
1 year
×
Clear all
No trials found.